Synergy CHC Secures $20 Million Loan Agreement

Synergy CHC ( (SNYR) ) has issued an announcement.

On May 30, 2025, Synergy CHC Corp. entered into a $20 million term loan credit agreement with ACP Agency, LLC, which includes a $15 million term loan and additional facilities. The agreement aims to repay existing debt and provide growth capital, enhancing the company’s financial stability and supporting its strategic goals.

The most recent analyst rating on (SNYR) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Synergy CHC stock, see the SNYR Stock Forecast page.

Spark’s Take on SNYR Stock

According to Spark, TipRanks’ AI Analyst, SNYR is a Neutral.

Synergy CHC presents a mixed outlook. While the stock is undervalued based on its P/E ratio, significant financial risks due to high leverage and liquidity issues are concerning. The company’s bearish technical indicators and lack of a clear positive earnings call narrative further weigh down the score. On the positive side, corporate events such as leadership changes and strategic partnerships suggest potential future growth.

To see Spark’s full report on SNYR stock, click here.

More about Synergy CHC

Synergy CHC Corp. is a provider of consumer health care and lifestyle products, with a brand portfolio that includes FOCUSfactor, a brain health supplement, and Flat Tummy, a wellness brand aimed at women’s weight management.

Average Trading Volume: 1,089,907

Technical Sentiment Signal: Sell

Current Market Cap: $15.86M

For an in-depth examination of SNYR stock, go to TipRanks’ Stock Analysis page.